Nachrichten zur Bruker Corp. Aktie

Bruker shares tumble 7% as Q2 on earnings miss, guidance cut…

Key PointsGAAP revenue missed analyst estimates, totaling $797.4 million for Q2 2025 and Revenue declined 0.4% year-over-year compared to Q2…

Geschäftstreiber: Bruker (BRKR) hat sich auf die Entwicklung von High-End-Analytic- und Diagnostik-Geräte für die Bereiche Medizintechnik, Biowissenschaften, bei Pharma-Anwendungen sowie…

Bruker launches the QSee™ quality control (QC) suite of software and reference materials for automated evaluation of instrument performance and…

Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasnt been having it easy in the past few days on the…

Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.…

…

…

Geschäftstreiber: Bruker (BRKR) hat sich auf die Entwicklung von High-End-Analytic- und Diagnostik-Geräte für die Bereiche Medizintechnik, Biowissenschaften, bei Pharma-Anwendungen sowie…

Brukers new technology, EpicIF, is set to enhance the CellScape Precise Spatial Proteomics platform.…

Bruker delivers robust revenue growth in the third quarter despite soft general market conditions.…

Bruker announces the formation of the new Bruker Spatial Biology division.…

At the Neuroscience 2024 conference, Bruker released its latest OptoVolt module, which seamlessly integrates with Ultima 2Pplus microscope and NeuraLight…

Brukers robust growth potential across its Nano segment is encouraging. Yet, unfavorable currency movement is likely to pose a challenge.…

Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Diagnostic Imaging Market Global Forecast Report By Product, Application, End…

Bruker (BRKR) installs the 1.2 GHz Avance NMR Spectrometer at KBSI, enabling advanced scientific discoveries.…

Bruker (BRKR) invests in NovAliX to accelerate advancements in drug discovery, combining cutting-edge biophysical methods and technologies to develop new…

Bruker (BRKR) delivers robust revenue growth in the second quarter despite soft general market conditions.…

Brukers (BRKR) NANO Life Science fluorescence microscopy is gaining from product innovation and research demand.…

Bruker (BRKR) completes the installation of its 1.2 (GHz) Avance nuclear magnetic resonance (NMR) spectrometer at the Leibniz Forschungsinstitut f??r…

Brukers (BRKR) NANO Life Science fluorescence microscopy is gaining from product innovation and research demand, further bolstered by the addition…

Brukers (BRKR) neofleX is a versatile, high-performance and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers.…

Brukers (BRKR) BSI Nano business is seeing robust revenue growth across its end markets, including academic, government, industrial and semiconductor…

Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.…

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical…

Brukers (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.…

Bruker beats Q1 EPS estimates, misses on revenue…

Brukers (BRKR) strong potential across the NANO and BioSpin segments bodes well for investors.…

Bruker (BRKR) revenues continue to be driven by the strength of end markets, including academic, government and industrial.…

…

Brukers (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.…

Bruker (BRKR) advances CCS-Enabled 4D-Proteomics timsTOF solutions for immunopeptidomes and glycoproteomics at the US HUPO 2024.…

The strength of the BSI BioSpin and CALID groups bodes well for Bruker (BRKR).…

UBS raises Bruker stock target to $102, maintains buy rating…

Bruker (BRKR) announces a share purchase agreement to acquire the molecular diagnostics innovator ELITechGroup.…